rs11557064

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_016098.4(MPC1):​c.106C>A​(p.Leu36Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0242 in 1,613,922 control chromosomes in the GnomAD database, including 634 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.020 ( 45 hom., cov: 33)
Exomes 𝑓: 0.025 ( 589 hom. )

Consequence

MPC1
NM_016098.4 missense

Scores

1
3
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 9.23

Publications

12 publications found
Variant links:
Genes affected
MPC1 (HGNC:21606): (mitochondrial pyruvate carrier 1) The protein encoded by this gene is part of an MPC1/MPC2 heterodimer that is responsible for transporting pyruvate into mitochondria. The encoded protein is found in the inner mitochondrial membrane. Defects in this gene are a cause of mitochondrial pyruvate carrier deficiency. Several transcript variants, some protein coding and one non-protein coding, have been found for this gene. [provided by RefSeq, Aug 2012]
MPC1 Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • mitochondrial pyruvate carrier deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a chain Mitochondrial pyruvate carrier 1 (size 107) in uniprot entity MPC1_HUMAN there are 6 pathogenic changes around while only 2 benign (75%) in NM_016098.4
BP4
Computational evidence support a benign effect (MetaRNN=0.010059357).
BP6
Variant 6-166366861-G-T is Benign according to our data. Variant chr6-166366861-G-T is described in ClinVar as Benign. ClinVar VariationId is 138240.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0198 (3009/152284) while in subpopulation AMR AF = 0.0372 (569/15292). AF 95% confidence interval is 0.0347. There are 45 homozygotes in GnomAd4. There are 1361 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 45 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MPC1NM_016098.4 linkc.106C>A p.Leu36Ile missense_variant Exon 3 of 5 ENST00000360961.11 NP_057182.1 Q9Y5U8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MPC1ENST00000360961.11 linkc.106C>A p.Leu36Ile missense_variant Exon 3 of 5 5 NM_016098.4 ENSP00000354223.6 Q9Y5U8

Frequencies

GnomAD3 genomes
AF:
0.0198
AC:
3010
AN:
152166
Hom.:
45
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00611
Gnomad AMI
AF:
0.0515
Gnomad AMR
AF:
0.0373
Gnomad ASJ
AF:
0.0167
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00393
Gnomad FIN
AF:
0.00377
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0290
Gnomad OTH
AF:
0.0224
GnomAD2 exomes
AF:
0.0173
AC:
4356
AN:
251432
AF XY:
0.0175
show subpopulations
Gnomad AFR exome
AF:
0.00560
Gnomad AMR exome
AF:
0.0177
Gnomad ASJ exome
AF:
0.0166
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00545
Gnomad NFE exome
AF:
0.0275
Gnomad OTH exome
AF:
0.0215
GnomAD4 exome
AF:
0.0246
AC:
36006
AN:
1461638
Hom.:
589
Cov.:
31
AF XY:
0.0241
AC XY:
17510
AN XY:
727112
show subpopulations
African (AFR)
AF:
0.00472
AC:
158
AN:
33478
American (AMR)
AF:
0.0182
AC:
813
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0172
AC:
450
AN:
26130
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39696
South Asian (SAS)
AF:
0.00342
AC:
295
AN:
86252
European-Finnish (FIN)
AF:
0.00575
AC:
307
AN:
53414
Middle Eastern (MID)
AF:
0.0317
AC:
183
AN:
5768
European-Non Finnish (NFE)
AF:
0.0291
AC:
32403
AN:
1111784
Other (OTH)
AF:
0.0231
AC:
1396
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
1839
3677
5516
7354
9193
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1210
2420
3630
4840
6050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0198
AC:
3009
AN:
152284
Hom.:
45
Cov.:
33
AF XY:
0.0183
AC XY:
1361
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.00609
AC:
253
AN:
41558
American (AMR)
AF:
0.0372
AC:
569
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0167
AC:
58
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00394
AC:
19
AN:
4828
European-Finnish (FIN)
AF:
0.00377
AC:
40
AN:
10606
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0290
AC:
1971
AN:
68020
Other (OTH)
AF:
0.0222
AC:
47
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
151
302
453
604
755
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0231
Hom.:
102
Bravo
AF:
0.0212
TwinsUK
AF:
0.0329
AC:
122
ALSPAC
AF:
0.0280
AC:
108
ESP6500AA
AF:
0.00499
AC:
22
ESP6500EA
AF:
0.0293
AC:
252
ExAC
AF:
0.0167
AC:
2030
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0289
EpiControl
AF:
0.0337

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 22, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
Dec 09, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Uncertain
0.0
CADD
Benign
21
DANN
Benign
0.85
DEOGEN2
Benign
0.35
T;T
Eigen
Benign
-0.17
Eigen_PC
Benign
0.13
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.96
D;D
MetaRNN
Benign
0.010
T;T
MetaSVM
Benign
-0.89
T
MutationAssessor
Benign
1.1
L;.
PhyloP100
9.2
PROVEAN
Benign
-0.37
N;.
REVEL
Uncertain
0.33
Sift
Benign
0.75
T;.
Sift4G
Benign
1.0
T;T
Polyphen
0.0060
B;.
Vest4
0.26
MPC
0.72
ClinPred
0.072
T
GERP RS
5.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.7
Varity_R
0.14
gMVP
0.74
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11557064; hg19: chr6-166780349; COSMIC: COSV99055087; API